Q8 treatment of CRC ex vivo explants showed no significant difference in expression of VEGF, PIGF (Figure 3), VEGF-C, VEGF-D, and FLT1 (Figure 4) from the angiogenic panel. Here, FLT1 is linked to colorectal carcinoma.